The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ACHIEVE LIFE SCIENCE INC COM 004468500 4,810,240 736,637 SH SOLE 736,637 0 0
ALECTOR INC COM 014442107 4,223,147 2,101,068 SH SOLE 2,101,068 0 0
ALKERMES PLC SHS G01767105 28,496,383 543,876 SH SOLE 543,876 0 0
ALUMIS INC COM 022307102 11,047,032 392,574 SH SOLE 392,574 0 0
ALTO NEUROSCIENCE INC COM SHS 02157Q109 35,706,910 1,353,047 SH SOLE 1,353,047 0 0
AN2 THERAPEUTICS INC COM 037326105 8,039,593 1,661,073 SH SOLE 1,661,073 0 0
PERSPECTIVE THERAPEUTICS INC COM NEW 46489V302 12,596,305 3,693,931 SH SOLE 3,693,931 0 0
CORVUS PHARMACEUTICALS INC COM 221015100 3,459,880 231,585 SH SOLE 231,585 0 0
DIANTHUS THERAPEUTICS INC COM 252828108 34,587,464 354,816 SH SOLE 354,816 0 0
ENLIVEN THERAPEUTICS INC COM 29337E102 16,697,055 329,006 SH SOLE 329,006 0 0
ENANTA PHARMACEUTICALS INC COM 29251M106 15,873,698 1,088,731 SH SOLE 1,088,731 0 0
ERASCA INC COM 29479A108 7,740,988 422,543 SH SOLE 422,543 0 0
HELIX ACQUISITION CORP III USD CL A ORD SHS G4444S107 5,320,000 500,000 SH SOLE 500,000 0 0
INFLARX NV COM N44821101 11,988,924 5,352,198 SH SOLE 5,352,198 0 0
INHIBIKASE THERAPEUTICS INC COM NEW 45719W205 7,270,654 3,581,603 SH SOLE 3,581,603 0 0
CENTURY THERAPEUTICS INC COM 15673T100 9,944,682 4,059,054 SH SOLE 4,059,054 0 0
JATT II ACQUISITION CORP ORD SHS G50765109 1,817,600 160,000 SH SOLE 160,000 0 0
KINIKSA PHARMACEUTICALS INTL ORD SHS CL A G52694109 58,710,577 918,070 SH SOLE 918,071 0 0
LB PHARMACEUTICALS INC COM SHS 50180M108 44,663,240 1,376,159 SH SOLE 1,376,159 0 0
LEONABIO INC COM 04746L203 3,618,112 393,701 SH SOLE 393,701 0 0
LEXEO THERAPEUTICS INC COM 52886X107 4,322,600 928,593 SH SOLE 928,593 0 0
MINERVA NEUROSCIENCES INC COM NEW 603380205 9,188,025 1,655,500 SH SOLE 1,655,500 0 0
VAXCYTE INC COM 92243G108 17,790,512 306,047 SH SOLE 306,047 0 0
RESEARCH ALLIANCE CORP III ORD SHS CL A G75226103 5,350,000 500,000 SH SOLE 500,000 0 0
RELAY THERAPEUTICS INC COM 75943R102 55,832,979 2,984,125 SH SOLE 2,984,125 0 0
RELMADA THERAPEUTICS INC COM 75955J402 44,227,990 6,391,328 SH SOLE 6,391,328 0 0
SAB BIOTHERAPEUTICS INC COM NEW 78397T202 8,574,158 2,198,502 SH SOLE 2,198,502 0 0
SURROZEN INC COM NEW 86889P208 11,211,438 432,040 SH SOLE 432,040 0 0
SAVARA INC COM 805111101 21,267,868 3,452,576 SH SOLE 3,452,576 0 0
ZAI LAB LTD ADR 98887Q104 5,303,090 279,110 SH SOLE 279,110 0 0